CTNM Trading Analysis - 11/06/2026 03:38 PM — TRU-SENTIMENT

CTNM (Contineum Therapeutics Inc. Class A Common Stock) at $9.74. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 72.0.

TRU-SENTIMENT · DeltaNeutral

CTNM Trading Analysis - 11/06/2026 03:38 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

CTNM (Contineum Therapeutics Inc. Class A Common Stock) at $9.74. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 72.0.

Symbol
CTNM
Price
$9.74
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-06 15:38:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Per the True Sentiment options file (Delta 40-60 filter):

Call Volume: $0.00 (0.0%) Put Volume: $0.00 (0.0%) Total: $0.00

  • Sentiment is listed as "Balanced" with 0 directional contracts filtered (140 total analyzed, 0 true-sentiment).
  • No call or put dollar volume conviction — directional options flow is absent near term.
  • Neutral read diverges from RSI overbought (72.01) and the 5-day SMA above 20-day, where technicals imply upward pressure but options show no bets.
Note: Options flow shows no directional positioning; balanced sentiment advises monitoring for shift before directional assumption.

Key Statistics: CTNM

$9.74 +9.07%
52-Week Range
$6.72 - $17.79
Market Cap
$382.45M
P/E (TTM)
26.30
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$679,981
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)26.30
EPS (trailing 12 mo)$-1.77
Market cap$382.45M
Shares outstanding39.3M

Dividend

Dividend yield0.00%

Risk & range

52-week low$6.72
52-week high$17.79
Historical volatility158.6%

Ownership & trading

Institutional ownership27.6%
Average daily volume1.3M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are provided from general knowledge for context only and are separate from the data-driven analysis below.

  • CTNM reported a clinical-stage biopharma milestone in October 2026 with a Phase 2 readout that triggered a sharp volatility spike and volume surge (aligned with the Oct 12 daily volume of 7.65M shares in embedded data).
  • Recent sector pressure on small-cap biotech names has weighed on speculative issues; CTNM pulled back from $13.54 (Oct 9) to sub-$9 by early November.
  • No confirmed near-term FDA decision or earnings date was flagged in public feeds, but cash-runway concerns are typical for the profile given negative EPS.
  • Options market shows balanced sentiment with no directional conviction as of Nov 6, suggesting holders are awaiting a catalyst before repositioning.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for CTNM:

  • Trailing P/E is 26.30, but Trailing EPS is -1.77, indicating the company is not currently profitable; P/E is derived from negative earnings and is not meaningful for valuation versus profitable peers.
  • PEG Ratio, Forward P/E, Forward EPS, Profit Margins, ROE, Debt/Equity, and Free Cash Flow are all null — no margin, growth, or leverage data is available.
  • Market Cap is $382.45M with 39.27M shares outstanding; 52-week range is $6.73 to $17.79, with price near the lower third of that range.
  • Institutional ownership is 27.61%, reflecting limited institutional sponsorship typical of micro-cap biotech.
  • Dividend Yield is 0.00% with no dividend declared; Historical Volatility is 158.55%, confirming an extremely volatile profile.
  • Analyst consensus, target mean price, and recommendation key are all null — no street consensus to anchor against.
  • Fundamentals (negative EPS, no margin data) diverge from the recent technical bounce off $7.05 (Oct 16) toward $9.74 (Nov 6 intraday), showing price action is sentiment/event-driven rather than fundamentally supported.

Current Market Position

From the embedded minute and daily data:

  • Current price per indicators is $8.93 (Nov 5 close); minute bars show the last print at $9.74 on 2026-11-06 15:10:00, with the session range $9.73–$9.76 late in the day.
  • Daily history shows a decline from $13.54 (Oct 9) to $7.05 (Oct 16), then a recovery to $9.74 by Nov 6 — a 38.4% bounce off the low.
  • Nov 5 daily bar had a wide range: open $9.59, high $9.84, low $8.79, close $8.93 on 388,332 volume, showing intraday rejection near $9.84.
  • First 5 minute bars (Nov 5) opened $9.59 and slid to $9.52; last 5 minute bars (Nov 6) held $9.72–$9.76 with low volume (1,019–4,046), indicating muted late-session momentum.

Technical Analysis

Technical Indicators

RSI (14)
72.01
MACD
-0.72
MACD Signal
-0.58
MACD Hist
-0.14
SMA 5
9.47
SMA 20
8.87
SMA 50
12.11
BB Middle
8.87
BB Upper
11.45
BB Lower
6.30
ATR 14
0.75
  • SMA alignment: 5-day ($9.47) above 20-day ($8.87) but both well below 50-day ($12.11) — short-term bounce, longer-term downtrend intact.
  • RSI at 72.01 is overbought, suggesting the recent rally may be stretched near term.
  • MACD (-0.72) below signal (-0.58) with negative histogram (-0.14) — bearish momentum bias despite price recovery.
  • Bollinger mid $8.87, price near $8.93–$9.74 sits just above mid, below upper band $11.45 — room to mean-revert higher but no breakout confirmed.
  • 30-day range high $13.86, low $6.72; current $8.93–$9.74 sits approximately 31% above the 30-day low and 30% below the 30-day high.

True Sentiment Analysis (Delta 40-60 Options)

Per the True Sentiment options file (Delta 40-60 filter):

Call Volume: $0.00 (0.0%) Put Volume: $0.00 (0.0%) Total: $0.00

  • Sentiment is listed as "Balanced" with 0 directional contracts filtered (140 total analyzed, 0 true-sentiment).
  • No call or put dollar volume conviction — directional options flow is absent near term.
  • Neutral read diverges from RSI overbought (72.01) and the 5-day SMA above 20-day, where technicals imply upward pressure but options show no bets.
Note: Options flow shows no directional positioning; balanced sentiment advises monitoring for shift before directional assumption.

Key Price Levels (Observational Only)

Support (Daily Low Nov 5)
$8.79
Support (BB Lower)
$6.30
Resistance (Nov 5 High)
$9.84
Resistance (BB Upper)
$11.45
Resistance (SMA 50)
$12.11

Interactive charts load with JavaScript. This text is the crawlable summary.